ReiThera vs Thermo Fisher Scientific: CDMO Comparison

Side-by-side comparison of ReiThera and Thermo Fisher Scientific on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Rome, IT
Signal Score
71/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
4
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
1
Capacity
Modalities
Adenoviral, AAV
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score
83/100
Quality (FDA + GMP)
98/100
FDA inspections
5
— NAI / VAI / OAI
2 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
1
MHRA GMP certificates (compliant)
9
Clinical programs (matched)
2
Capacity
Available
Modalities
AAV, Lentiviral, Plasmid DNA, Adenoviral

Key differences

  • Thermo Fisher Scientific has more FDA inspections on record (5 vs 0) — a deeper regulatory paper trail.
  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • ReiThera has materially broader EMA GMP coverage (4 active certificates vs 1) — stronger EU footprint.
  • Thermo Fisher Scientific maintains 9 MHRA / UK GMP certificates; ReiThera does not.
  • Composite Signal Score: Thermo Fisher Scientific 83/100 vs ReiThera 71/100 — a 12-point gap reflecting the combined quality, capacity and financial signal.

On a 13-modality CDMO landscape, both ReiThera and Thermo Fisher Scientific qualify as AAV manufacturers; Thermo Fisher Scientific carries the higher composite Signal Score for AAV programs in this comparison.

What to evaluate for AAV programs

Both ReiThera and Thermo Fisher Scientific qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Platform & scale

Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.

Capsid quality

Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.

Regulatory readiness

For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & timelines

AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.

See all AAV CDMOs ranked by Signal Score →

Frequently asked: ReiThera vs Thermo Fisher Scientific

Which has the stronger FDA inspection record, ReiThera or Thermo Fisher Scientific?

Both ReiThera and Thermo Fisher Scientific maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. ReiThera has 0 FDA inspections on record; Thermo Fisher Scientific has 5.

How do ReiThera and Thermo Fisher Scientific compare on European GMP coverage?

ReiThera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Thermo Fisher Scientific holds 1 active EMA GMP certificate and 9 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — ReiThera or Thermo Fisher Scientific?

ReiThera is matched to 1 ClinicalTrials.gov record as a manufacturing partner; Thermo Fisher Scientific is matched to 2. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

Which is better for AAV manufacturing — ReiThera or Thermo Fisher Scientific?

Both ReiThera and Thermo Fisher Scientific are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

ReiThera carries a Signal Score of 71/100 and Thermo Fisher Scientific carries 83/100 — a meaningful lead for Thermo Fisher Scientific. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating ReiThera and Thermo Fisher Scientific for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.